Blog Archive

Pain of any kind has a way of commanding all of your attention, and that’s certainly true of migraine, which the 1 billion people around the world who report migraines can confirm. Closer to home, 3%-5% of the US population suffers from chronic migraines, which we define as having 15...

You’re worried about a health issue, you’re stressed about a new project, or fear prevents you from doing anything where heights are involved. These are all perfectly normal manifestations of stress and anxiety and usually not cause for concern. Unfortunately, for millions of Americans (40 million 18 and older, to...

You cut your finger and experience sharp pain that turns into a dull ache as the wound heals. But heal it does, and the pain goes away. With peripheral neuropathy, the path to relief isn’t as simple because you're not dealing with an injury that can heal but with nerves...

Major depression affects 10-15% of women, men, and kids in the United States each year. About 10-30% of them don’t get relief from traditional antidepressant therapy.  Although ketamine and antidepressants each target brain chemicals that regulate mood, that's where their similarities end. Ketamine works differently from the way antidepressants do....

Is Spravato More Effective than Ketamine? To much fanfare, Johnson & Johnson’s drug company, Janssen Pharmaceuticals Inc., has been testing a new drug for treatment-resistant depression, Spravato – also known as esketamine. Chemically, the generic ketamine and Jonson & Johnson’s patented Spravato are very similar. Spravato will undoubtedly be much...

Esketamine Does Not Live Up to Hopes for a More Convenient Ketamine Eskatmine (brand name Spravato) is a new nasal spray that works like ketamine. To treat depression, ketamine has been delivered through an IV or breathed in as a nebulizer treatment. The idea of a nasal spray has been...

How Much Does Spravato Cost? Spravato (generic name esketamine) is the newly patented and newly FDA approved modification of ketamine. It’s been released by Johnson & Johnson’s Janssen Pharmaceuticals, Inc. with much fanfare. They claim it’s a new kind of drug for treatment-resistant depression. Unfortunately, it’s hard to find any...

Is Spravato Nasal Spray for Depression Really New? In March 2019, the FDA approved Johnson & Johnson’s new depression drug. Company spokespeople have said it uses the “first new mechanism of action in decades.” That means it should work on the body in a new way. But wait . ....